We confirmed that the majority of subjects with AUD have significant liver disease compared with control volunteers, and after 2 weeks of abstinence exhibit a significantly ameliorated liver damage marker CK18-M65 and steatosis marker CAP (both with P value < 0.001). The gene discussed is KRT18; the disease is medical procedure.